­Mutaflor in other diseases

A prospective post-marketing surveillance study including 3.807 patients revealed the extraordinary width of the empirical-based therapeutic spectrum and actions of E. coli strain Nissle 1917 (­Mutaflor).52

Apart from diarrhea and the irritable bowel syndrome, EcN has also been applied in cases of extraintestinal diseases such as neurodermitis or urinary tract ­infections.

Therapeutic experiences with E. coli strain Nissle 1917 based on results52

52) Krammer H et al. ­Probiotische Arzneimitteltherapie mit E. coli Stamm Nissle 1917 (EcN): ­Ergebnisse einer prospektiven Datenerhebung mit 3807 Patienten. Z Gastroenterol 2006; 44: 651–656.

Mutaflor international package insert to download
Mutaflor Suspension international package insert to download